NewAmsterdam Pharma Company NV Warrant (NAMSW) had the highest return in Q3 2022 by a US stock in the Biotechnology Industry, returning 841.3%.

ASSET	QUARTER	% RETURN
NewAmsterdam Pharma Company NV Warrant (NAMSW)	Q3 2022	841.25%
Rhythm Pharmaceuticals (RYTM)	Q3 2022	500.49%
Akero Therapeutics (AKRO)	Q3 2022	251.76%
Astria Therapeutics (ATXS)	Q3 2022	202.34%
NRx Pharmaceuticals (NRXPW)	Q3 2022	184.36%
Bioatla (BCAB)	Q3 2022	170.18%
Minerva Neurosciences (NERV)	Q3 2022	165.99%
Immuneering (IMRX)	Q3 2022	165.19%
Spero Therapeutics (SPRO)	Q3 2022	163.16%
Pliant Therapeutics (PLRX)	Q3 2022	161.45%
NLS Pharmaceutics (NLSPW)	Q3 2022	147.52%
AN2 Therapeutics (ANTX)	Q3 2022	126.3%
Pasithea Therapeutics Corp Warrant (KTTAW)	Q3 2022	124.24%
Prothena (PRTA)	Q3 2022	122.33%
Acumen Pharmaceuticals (ABOS)	Q3 2022	112.95%
Ardelyx (ARDX)	Q3 2022	105.17%
Kalaris Therapeutics (KLRS)	Q3 2022	102.31%
Caribou Biosciences (CRBU)	Q3 2022	92.87%
Rallybio (RLYB)	Q3 2022	92.42%
Seres Therapeutics (MCRB)	Q3 2022	92.22%
Dyne Therapeutics (DYN)	Q3 2022	84.59%
Catalyst Pharmaceuticals (CPRX)	Q3 2022	83.55%
InflaRx (IFRX)	Q3 2022	82.07%
89bio (ETNB)	Q3 2022	81.5%
Viridian Therapeutics (VRDN)	Q3 2022	76.81%